{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:28:01Z","timestamp":1787041681753,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ejmech.2026.119097","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T23:31:01Z","timestamp":1782257461000},"page":"119097","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Enabling lead optimization with a focus on optimal dose selection by utilizing multi-parametric data visualization techniques"],"prefix":"10.1016","volume":"317","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-1484-550X","authenticated-orcid":false,"given":"J\u00f6rg","family":"Berghausen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh","family":"Rajaraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujal","family":"Deshmukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.ejmech.2026.119097_bib1","doi-asserted-by":"crossref","first-page":"12156","DOI":"10.1021\/acs.jmedchem.9b01813","article-title":"Integrating the impact of lipophilicity on potency and pharmacokinetic parameters enables the use of diverse chemical space during small molecule drug optimization","volume":"63","author":"Miller","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119097_bib2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.addr.2016.04.018","article-title":"The solubility\u2013permeability interplay and oral drug formulation design: two heads are better than one","volume":"101","author":"Dahan","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"15","key":"10.1016\/j.ejmech.2026.119097_bib3","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.1021\/acs.jmedchem.5b00201","article-title":"Volume of distribution in drug design","volume":"58","author":"Smith","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119097_bib4","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.5c00880","article-title":"Insights on volume of distribution of acids","author":"Smith","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119097_bib5","doi-asserted-by":"crossref","first-page":"88","DOI":"10.18433\/jpps29896","article-title":"Clearance concepts: fundamentals and application to pharmacokinetic behavior of drugs","volume":"21","author":"Mehvar","year":"2018","journal-title":"J. Pharm. Pharm. Sci."},{"issue":"8","key":"10.1016\/j.ejmech.2026.119097_bib6","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1124\/dmd.124.001649","article-title":"After 50 years of hepatic clearance models, where should we Go from here? Improvements and implications for physiologically based pharmacokinetic modeling","volume":"52","author":"Pang","year":"2024","journal-title":"Drug Metabol. Dispos."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119097_bib7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1208\/s12248-021-00591-z","article-title":"There is only one valid definition of clearance: critical examination of clearance concepts reveals the potential for errors in clinical drug dosing decisions","volume":"23","author":"Benet","year":"2021","journal-title":"AAPS J."},{"issue":"5","key":"10.1016\/j.ejmech.2026.119097_bib8","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1021\/acs.jmedchem.8b01263","article-title":"Clearance in drug design","volume":"62","author":"Smith","year":"2019","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119097_bib9","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1124\/dmd.121.000637","article-title":"In defense of current concepts and applications of clearance in drug development and therapeutics","volume":"50","author":"Rowland","year":"2022","journal-title":"Drug Metabol. Dispos."},{"key":"10.1016\/j.ejmech.2026.119097_bib10","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.9b01365","article-title":"Dose predictions for drug design","author":"Maurer","year":"2020","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2026.119097_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103758","article-title":"Towards holistic compound quality scores: extending ligand efficiency indices with compound pharmacokinetic characteristics","volume":"28","author":"Tautermann","year":"2023","journal-title":"Drug Discov. Today"},{"issue":"4","key":"10.1016\/j.ejmech.2026.119097_bib12","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1021\/mp500504q","article-title":"Preclinical dose number and its application in understanding drug absorption risk and formulation design for preclinical species","volume":"12","author":"Wuelfing","year":"2015","journal-title":"Mol. Pharm."},{"issue":"Supplement C","key":"10.1016\/j.ejmech.2026.119097_bib13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejps.2017.02.017","article-title":"How to identify and eliminate compounds with a risk of high clinical dose during the early phase of lead optimisation in drug discovery","volume":"110","author":"Teague","year":"2017","journal-title":"Eur. J. Pharmaceut. Sci."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119097_bib14","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1021\/acs.molpharmaceut.5b00840","article-title":"Validation of early human dose prediction: a key metric for compound progression in drug discovery","volume":"13","author":"Page","year":"2016","journal-title":"Mol. Pharm."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119097_bib15","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1021\/mp300476z","article-title":"Application of in silico, in vitro and preclinical pharmacokinetic data for the effective and efficient prediction of human pharmacokinetics","volume":"10","author":"Grime","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2026.119097_bib16","first-page":"1","article-title":"Estimating human ADME properties, pharmacokinetic parameters and likely clinical dose in drug discovery","author":"Lucas","year":"2019","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.119097_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128003","article-title":"Holistic drug design for multiparameter optimization in modern small molecule drug discovery","volume":"41","author":"Pennington","year":"2021","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"20","key":"10.1016\/j.ejmech.2026.119097_bib18","doi-asserted-by":"crossref","first-page":"14047","DOI":"10.1021\/acs.jmedchem.3c01083","article-title":"Prediction of small-molecule developability using large-scale in Silico ADMET models","volume":"66","author":"Beckers","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119097_bib19","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.7b00969","article-title":"Relevance of half-life in drug design","author":"Smith","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119097_bib20","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.2174\/138161212799436430","article-title":"Multi-Parameter optimization: identifying high quality compounds with a balance of properties","volume":"18","author":"Segall","year":"2012","journal-title":"Curr. Pharm. Des."},{"issue":"5","key":"10.1016\/j.ejmech.2026.119097_bib21","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2174\/138920007780866799","article-title":"Evaluation of human pharmacokinetics, therapeutic dose and exposure predictions using marketed oral drugs","volume":"8","author":"McGinnity","year":"2007","journal-title":"Curr. Drug Metabol."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119097_bib22","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s11095-023-03482-4","article-title":"Simplifying the extended clearance concept classification System (EC3S) to guide clearance prediction in drug discovery","volume":"40","author":"Patel","year":"2023","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejmech.2026.119097_bib23","first-page":"1","article-title":"An update on the importance of plasma protein binding in drug discovery and development","author":"Di","year":"2021","journal-title":"Expert Opin. Drug Discov."},{"issue":"8","key":"10.1016\/j.ejmech.2026.119097_bib24","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1124\/dmd.119.087163","article-title":"Plasma protein binding as an optimizable parameter for acidic drugs","volume":"47","author":"Gardiner","year":"2019","journal-title":"Drug Metabol. Dispos."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426005428?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426005428?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:04:27Z","timestamp":1787040267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426005428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":24,"alternative-id":["S0223523426005428"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119097","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enabling lead optimization with a focus on optimal dose selection by utilizing multi-parametric data visualization techniques","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119097","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119097"}}